{"id":23999,"date":"2021-06-08T06:33:27","date_gmt":"2021-06-08T06:33:27","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/es\/?post_type=scientific-materials&p=23999"},"modified":"2021-06-08T06:36:41","modified_gmt":"2021-06-08T06:36:41","slug":"estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica","status":"publish","type":"scientific-materials","link":"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica","title":{"rendered":"Estudio EPILAK. Calidad de vida en pacientes adultos con epilepsia generalizada idiop\u00e1tica"},"content":{"rendered":"

La calidad de vida es un aspecto importante en el tratamiento de los pacientes con epilepsia. El Objetivo de este estudio es analizar la calidad de vida mediante el Quality of Life in Epilepsy Inventory-10 (QOLIE-10) en adultos con epilepsia generalizada idiop\u00e1tica y estudiar factores asociados a una peor calidad de vida.<\/p>\n

Acceder al estudio EPILAK<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

La calidad de vida es un aspecto importante en el tratamiento de los pacientes con epilepsia. El Objetivo de este estudio es analizar la calidad de vida mediante el Quality of Life in Epilepsy Inventory-10 (QOLIE-10) en adultos con epilepsia generalizada idiop\u00e1tica y estudiar factores asociados a una peor calidad de vida.<\/p>\n","protected":false},"featured_media":23996,"template":"","categories":[157],"languages":[38],"specialties":[],"country":[26],"class_list":["post-23999","scientific-materials","type-scientific-materials","status-publish","has-post-thumbnail","hentry","categories-epilepsia","languages-es","country-spain"],"yoast_head":"\nEstudio EPILAK. Calidad de vida en pacientes adultos con epilepsia generalizada idiop\u00e1tica - Neuraxpharm Espa\u00f1a<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Estudio EPILAK. Calidad de vida en pacientes adultos con epilepsia generalizada idiop\u00e1tica\" \/>\n<meta property=\"og:description\" content=\"La calidad de vida es un aspecto importante en el tratamiento de los pacientes con epilepsia. El Objetivo de este estudio es analizar la calidad de vida mediante el Quality of Life in Epilepsy Inventory-10 (QOLIE-10) en adultos con epilepsia generalizada idiop\u00e1tica y estudiar factores asociados a una peor calidad de vida.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Espa\u00f1a\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-08T06:36:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neuraxpharm.com\/es\/wp-content\/uploads\/sites\/8\/2021\/06\/epilak.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1325\" \/>\n\t<meta property=\"og:image:height\" content=\"616\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica\",\"url\":\"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica\",\"name\":\"Estudio EPILAK. Calidad de vida en pacientes adultos con epilepsia generalizada idiop\u00e1tica - Neuraxpharm Espa\u00f1a\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/06\/epilak.jpg\",\"datePublished\":\"2021-06-08T06:33:27+00:00\",\"dateModified\":\"2021-06-08T06:36:41+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/06\/epilak.jpg\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/06\/epilak.jpg\",\"width\":1325,\"height\":616},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/es\/\",\"name\":\"Neuraxpharm Espa\u00f1a\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Estudio EPILAK. Calidad de vida en pacientes adultos con epilepsia generalizada idiop\u00e1tica - Neuraxpharm Espa\u00f1a","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica","og_locale":"es_ES","og_type":"article","og_title":"Estudio EPILAK. Calidad de vida en pacientes adultos con epilepsia generalizada idiop\u00e1tica","og_description":"La calidad de vida es un aspecto importante en el tratamiento de los pacientes con epilepsia. El Objetivo de este estudio es analizar la calidad de vida mediante el Quality of Life in Epilepsy Inventory-10 (QOLIE-10) en adultos con epilepsia generalizada idiop\u00e1tica y estudiar factores asociados a una peor calidad de vida.","og_url":"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica","og_site_name":"Neuraxpharm Espa\u00f1a","article_modified_time":"2021-06-08T06:36:41+00:00","og_image":[{"width":1325,"height":616,"url":"https:\/\/www.neuraxpharm.com\/es\/wp-content\/uploads\/sites\/8\/2021\/06\/epilak.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica","url":"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica","name":"Estudio EPILAK. Calidad de vida en pacientes adultos con epilepsia generalizada idiop\u00e1tica - Neuraxpharm Espa\u00f1a","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica#primaryimage"},"thumbnailUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/06\/epilak.jpg","datePublished":"2021-06-08T06:33:27+00:00","dateModified":"2021-06-08T06:36:41+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/estudio-epilak-calidad-de-vida-en-pacientes-adultos-con-epilepsia-generalizada-idiopatica#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/06\/epilak.jpg","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/06\/epilak.jpg","width":1325,"height":616},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/es\/#website","url":"https:\/\/www.neuraxpharm.com\/es\/","name":"Neuraxpharm Espa\u00f1a","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/scientific-materials\/23999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/scientific-materials"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/types\/scientific-materials"}],"version-history":[{"count":3,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/scientific-materials\/23999\/revisions"}],"predecessor-version":[{"id":24003,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/scientific-materials\/23999\/revisions\/24003"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/media\/23996"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/media?parent=23999"}],"wp:term":[{"taxonomy":"categories","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/categories?post=23999"},{"taxonomy":"languages","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/languages?post=23999"},{"taxonomy":"specialties","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/specialties?post=23999"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/country?post=23999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}